Page last updated: 2024-11-01

ofloxacin and Apoplexy

ofloxacin has been researched along with Apoplexy in 2 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research Excerpts

ExcerptRelevanceReference
" Levofloxacin and placebo patients had a cumulative rate of infection of 6% and 6% (P=0."5.11The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. ( Cervera, A; Chamorro, A; Horcajada, JP; Mensa, J; Obach, V; Planas, AM; Revilla, M; Torres, F; Vargas, M, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Redondo, M1
Zarruk, JG1
Ceballos, P1
Pérez, DI1
Pérez, C1
Perez-Castillo, A1
Moro, MA1
Brea, J1
Val, C1
Cadavid, MI1
Loza, MI1
Campillo, NE1
Martínez, A1
Gil, C1
Chamorro, A1
Horcajada, JP1
Obach, V1
Vargas, M1
Revilla, M1
Torres, F1
Cervera, A1
Planas, AM1
Mensa, J1

Trials

1 trial available for ofloxacin and Apoplexy

ArticleYear
The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial.
    Stroke, 2005, Volume: 36, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Body Temperature; Brain; Brain Ischemia; C-React

2005

Other Studies

1 other study available for ofloxacin and Apoplexy

ArticleYear
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.
    European journal of medicinal chemistry, 2012, Volume: 47, Issue:1

    Topics: Animals; Blood-Brain Barrier; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 7; Disease

2012